Visual Telerehabilitation in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour

What this study is about

Brain malignancies are the most common cause of death from cancer in the pediatric population and a major source of morbidity amongst survivors. Many children with a brain tumour often suffer from visual field defects (hemianopia) dramatically impacting their daily life with poorer social interaction, difficulties learning, playing sports and engaging with peers. Practically, they bump into people and objects and have problems in finding their way in unfamiliar places and in detecting incoming objects in their blind field. There is growing recognition of the diverse and deep impact of hemianopia on physical and mental health, quality of life, and social outcomes of the affected individuals and their family. However, despite the frequent impact of brain tumours on the visual function and functional vision, ophthalmologic evaluations are not standard of care for all brain tumour patients and there are no standardized protocols of vision loss management in the pediatric population with hemianopia. There is an unmet need of restoring perception in the blind field in individuals with hemianopia consecutive to pediatric brain tumor. Our laboratory has developed a visual rehabilitation procedure based on the combination of adaptative audio and visual target tracking in a 3D environment in virtual reality. Participants perform audiovisual stimulation at home in a headset, with remote control from the laboratory. Preliminary on data on paediatric patients with hemianopia consecutive to a brain tumour indicate feasibility and potential effectiveness of a 6-week Re:Vision program on visual fields, visual perception and quality of life. Our objective is to evaluate the effectiveness of Re:Vision, an 8-week visual telerehabilitation program, on visual perception in 50 individuals aged 10-40 years old with hemianopia consecutive to a pediatric brain tumor in a phase IIa/b multi-centric clinical study across Canada. This intervention provides more equitable access to individuals, with the ability to receive rehabilitation therapy at home without supervision by a healthcare professional, meaning that Canadians living outside urban centres could take advantage of specialized therapies with remote supervision. This is the first study that could lead to a major change in the management of these patients. It could open the door for visual rehabilitation strategies to other population of visually impaired children, significantly impacting public health strategies.

Who can join (things the study team will check)

✅ You may be able to join if…

• Diagnosed hemianopsia (\> 18 months).
• History of a diagnosis of brain tumour
• Being stable for the tumour for \>18 months (either on therapy or not)
• Male and female
• 10 - 40 years old
• Ability to follow the visual and auditory stimuli and training instructions.
• Online auditory test positive (-5dbHL to 60dbHL range) at 125 Hz (for research purposes only)
• Home Wi-Fi access.

🚫 You may not be able to join if…

• \< 10 years old.
• \> 40 years old.
• Ocular disease
• Both eyes with media opacity that impairs microperimetry testing.
• Inability to perform during testing and training.
• Recreational or medicinal consumption of psychoactive drugs.
• 3 consecutive VRISE (cybersickness) scores \< 25 at inclusion.
• History of vertigo or dizziness.
• Prior vision rehabilitation interventions.

Where this trial is running

• Alberta Children's Hospital, Calgary, Alberta, Canada
• British Columbia Children's Hospital, Vancouver, British Columbia, Canada
• The Hospital for Sick Children, Toronto, Ontario, Canada
• Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada
• CHU de Québec, Québec, Quebec, Canada

Who to contact

Michael Reber, PhD · 416-634-7937 · michael.reber@uhn.ca

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT06362434.